Cargando…
Coronavirus-induced coagulopathy during the course of disease
BACKGROUND: A significant proportion of patients with coronavirus disease 19 (COVID-19) suffer from excessive coagulation activation and coagulopathy which is associated with an increased risk of venous and arterial thromboembolism and adverse outcome. Our study investigates coagulation markers and...
Autores principales: | Friedrich, Marie Sophie, Studt, Jan-Dirk, Braun, Julia, Spahn, Donat R., Kaserer, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745968/ https://www.ncbi.nlm.nih.gov/pubmed/33332362 http://dx.doi.org/10.1371/journal.pone.0243409 |
Ejemplares similares
-
Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations
por: Kaserer, Alexander, et al.
Publicado: (2019) -
Point-of-Care Diagnostics in Coagulation Management
por: Sahli, Sebastian D., et al.
Publicado: (2020) -
Not all anemia is solely due to iron deficiency
por: Rössler, Julian, et al.
Publicado: (2020) -
Predictors associated with mortality of veno-venous extracorporeal membrane oxygenation therapy
por: Neumann, Elena, et al.
Publicado: (2023) -
Correction: Comparing Classroom Instruction to Individual Instruction as an Approach to Teach Avatar-Based Patient Monitoring With Visual Patient: Simulation Study
por: Rössler, Julian, et al.
Publicado: (2020)